A Strategic Investor’s View of the Biotech Investment Landscape

from The Bio Report · host Levine Media Group

When the BIO Investor Forum convenes in San Francisco October 17 and 18, a key point of discussion will be the availability of funding for emerging life sciences companies. One of the panelist addressing that issue this year will be Asish Xavier, vice president of venture investments for Johnson & Johnson Innovation’s venture arm JJDC. We spoke to Xavier about JJDC’s approach to investing as a strategic investor, the changing landscape for venture capital, and how competitive the environment is for access to compelling technologies today.

Episode metadata supplied by the publisher feed · Published Oct 5, 2017

Embed this episode

Attribution link and audio player

NOW PLAYING

A Strategic Investor’s View of the Biotech Investment Landscape

0:00 23:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Bio Report?

This episode is 23 minutes long.

When was this The Bio Report episode published?

This episode was published on October 5, 2017.

Can I download this The Bio Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!